St. James Investment Company buys $27,636,615 stake in Monsanto Company (MON)

Monsanto Company (MON) : St. James Investment Company scooped up 17,595 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 264,820 shares of Monsanto Company which is valued at $27,636,615.Monsanto Company makes up approximately 3.41% of St. James Investment Company’s portfolio.

Other Hedge Funds, Including , Ngam Advisors reduced its stake in MON by selling 39,502 shares or 70.75% in the most recent quarter. The Hedge Fund company now holds 16,330 shares of MON which is valued at $1,704,199. Monsanto Company makes up approx 0.02% of Ngam Advisors’s portfolio. Artemis Investment Management Llp added MON to its portfolio by purchasing 119,363 company shares during the most recent quarter which is valued at $12,742,000. Monsanto Company makes up approx 0.33% of Artemis Investment Management Llp’s portfolio.Cortland Associates Incmo reduced its stake in MON by selling 48,989 shares or 32.37% in the most recent quarter. The Hedge Fund company now holds 102,374 shares of MON which is valued at $10,928,425. Monsanto Company makes up approx 2.40% of Cortland Associates Incmo’s portfolio.Msi Financial Services Inc reduced its stake in MON by selling 1,973 shares or 22.86% in the most recent quarter. The Hedge Fund company now holds 6,657 shares of MON which is valued at $710,635. Monsanto Company makes up approx 0.02% of Msi Financial Services Inc’s portfolio.Osborne Partners Capital Management reduced its stake in MON by selling 33,484 shares or 77.93% in the most recent quarter. The Hedge Fund company now holds 9,485 shares of MON which is valued at $1,012,619. Monsanto Company makes up approx 0.15% of Osborne Partners Capital Management’s portfolio.

Monsanto Company opened for trading at $104.36 and hit $106.94 on the upside on Thursday, eventually ending the session at $106.42, with a gain of 1.97% or 2.06 points. The heightened volatility saw the trading volume jump to 49,51,389 shares. Company has a market cap of $46,567 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *